Perspectives from our Leadership team

“Our work at Generian is focused on translating research into drugs that can reverse the course of disease in humans. The goal is to help people live better longer.”
Toren Finkel, MD, PhD
“The Generian discovery platform we have built enables rapid and scalable target discovery through the use of proprietary tools and assays that pinpoint relevant target proteins, identify specific E3 ligases and develop small molecules for further studies.”
Bill Chen, PhD
VP, Drug Discovery
“The therapies we are developing are designed to inhibit specific E3 ligases, thereby preventing the degradation of beneficial target proteins to enhance cellular response and exert a beneficial effect.”
Yuan Liu, PhD
VP, Biology